Grey A - Search Results

1

Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors.

Douglas F, Petrie KJ, Cundy T, Horne A, Gamble G, Grey A. Douglas F, et al. Among authors: grey a. Osteoporos Int. 2012 Aug;23(8):2135-40. doi: 10.1007/s00198-011-1823-7. Epub 2011 Nov 8. Osteoporos Int. 2012. PMID: 22065304

2

Mechanisms of cortical bone loss from the metacarpal following digital amputation.

Cundy T, Grey A. Cundy T, et al. Among authors: grey a. Calcif Tissue Int. 1994 Sep;55(3):164-8. doi: 10.1007/BF00425869. Calcif Tissue Int. 1994. PMID: 7987727

3

Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.

Grey AB, Cundy TF, Reid IR. Grey AB, et al. Clin Endocrinol (Oxf). 1994 May;40(5):671-7. doi: 10.1111/j.1365-2265.1994.tb03020.x. Clin Endocrinol (Oxf). 1994. PMID: 8013147

4

Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.

Grey A, Cundy T, Evans M, Reid I. Grey A, et al. Clin Endocrinol (Oxf). 1996 Mar;44(3):293-6. doi: 10.1046/j.1365-2265.1996.667488.x. Clin Endocrinol (Oxf). 1996. PMID: 8729524

5

Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women.

Orr-Walker BJ, Horne AM, Evans MC, Grey AB, Murray MA, McNeil AR, Reid IR. Orr-Walker BJ, et al. Among authors: grey ab. J Clin Endocrinol Metab. 1999 Jun;84(6):1997-2001. doi: 10.1210/jcem.84.6.5797. J Clin Endocrinol Metab. 1999. PMID: 10372700 Clinical Trial.

6

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR. Orr-Walker BJ, et al. Among authors: grey ab. Arch Intern Med. 2000 Jul 24;160(14):2161-6. doi: 10.1001/archinte.160.14.2161. Arch Intern Med. 2000. PMID: 10904459 Clinical Trial.

7

A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.

Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J. Cundy T, et al. Among authors: grey ab. Hum Mol Genet. 2002 Sep 1;11(18):2119-27. doi: 10.1093/hmg/11.18.2119. Hum Mol Genet. 2002. PMID: 12189164

8

Association between primary hyperparathyroidism and increased body weight: a meta-analysis.

Bolland MJ, Grey AB, Gamble GD, Reid IR. Bolland MJ, et al. J Clin Endocrinol Metab. 2005 Mar;90(3):1525-30. doi: 10.1210/jc.2004-1891. Epub 2004 Dec 21. J Clin Endocrinol Metab. 2005. PMID: 15613408

9

Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Grey A, et al. J Clin Endocrinol Metab. 2005 Apr;90(4):2122-6. doi: 10.1210/jc.2004-1772. Epub 2005 Jan 11. J Clin Endocrinol Metab. 2005. PMID: 15644400

10

beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.

Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC. Reid IR, et al. J Bone Miner Res. 2005 Apr;20(4):613-8. doi: 10.1359/JBMR.041202. Epub 2004 Dec 6. J Bone Miner Res. 2005. PMID: 15765180 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

756 results

Search Page

Filters